Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 11,300 shares at $4.20 ($48K) on 2008-01-04, disclosed to the SEC on 2008-01-07.
Open-market purchase of $48k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.13 | 100 | $413 | 0.9% |
| 2 | $4.14 | 200 | $828 | 1.7% |
| 3 | $4.15 | 100 | $415 | 0.9% |
| 4 | $4.16 | 300 | $1K | 2.6% |
| 5 | $4.17 | 300 | $1K | 2.6% |
| 6 | $4.18 | 600 |
| $3K |
| 5.3% |
| 7 | $4.19 | 300 | $1K | 2.6% |
| 8 | $4.20 | 800 | $3K | 7.0% |
| 9 | $4.21 | 1,787 | $8K | 15.8% |
| 10 | $4.22 | 741 | $3K | 6.6% |
| 11 | $4.23 | 2,207 | $9K | 19.6% |
| 12 | $4.24 | 1,700 | $7K | 15.1% |
| 13 | $4.25 | 2,165 | $9K | 19.3% |
| Total | $4.22 avg | 11,300 | $48K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |